Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04594772 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Completion pushed from Jun 1, 2026 to Jun 1, 2027v10
  2. Completion date: Jan 1, 2026 to Jun 1, 2026v9
  3. Trial status: Recruiting to Active, Not Recruiting Primary completion date changed from estimate of Jun 1, 2025 to Jun 13, 2025 · Site details revised at 2 of 2 sitesv8 Show 2 more changesShow less
    • Primary completion date changed from estimate of Jun 1, 2025 to Jun 13, 2025
    • Site details revised at 2 of 2 sites
  4. Site details revised at 1 of 2 sitesv7
  5. Primary completion date: Jan 1, 2025 to Jun 1, 2025v6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary completion date: May 1, 2024 to Jan 1, 2025v5
  2. Primary completion date: May 1, 2023 to May 1, 2024v4
  3. Primary completion date: May 1, 2022 to May 1, 2023 Study sites: 1 to 2v3 Show 1 more changeShow less
    • Study sites: 1 to 2
  4. Trial status: Not Yet Recruiting to Recruiting Primary endpoint revised · Start date changed from estimate of Jan 1, 2021 to Mar 17, 2021 · Secondary endpoints revised (7) · 1 morev2 Show 4 more changesShow less
    • Primary endpoint revised
    • Start date changed from estimate of Jan 1, 2021 to Mar 17, 2021
    • Secondary endpoints revised (7)
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine if neoadjuvant therapy to increases resection rate for pancreatic adenocarcinoma.
Trial Details
NCT Number NCT04594772
Lead Sponsor University of Cincinnati
Conditions Pancreas Cancer
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov